Education
About Us
Working with TipRanks
Follow Us
Item 9 Labs Corp (INLB)
OTHER OTC:INLB
INLB Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume510.00
Average Volume (3M)N/A
Market Cap
$702.00
Enterprise Value$27.83M
Total Cash (Recent Filing)$183.43K
Total Debt (Recent Filing)$34.30M
Price to Earnings (P/E)―
Beta-0.46
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding701,806,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)<0.01
Price to Sales (P/S)0.00
P/FCF Ratio>-0.01
Enterprise Value/Market Cap39.64K
Enterprise Value/Revenue0.34
Enterprise Value/Gross Profit2.84
Enterprise Value/Ebitda-0.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
INLB FAQ
What was Item 9 Labs Corp’s price range in the past 12 months?
Currently, no data Available
What is Item 9 Labs Corp’s market cap?
Item 9 Labs Corp’s market cap is $702.00.
When is Item 9 Labs Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Item 9 Labs Corp’s earnings last quarter?
Item 9 Labs Corp released its earnings results on May 17, 2023. The company reported -$0.034 earnings per share for the quarter, beating the consensus estimate of -$0.04 by $0.006.
Is Item 9 Labs Corp overvalued?
According to Wall Street analysts Item 9 Labs Corp’s price is currently Overvalued.
Does Item 9 Labs Corp pay dividends?
Item 9 Labs Corp does not currently pay dividends.
What is Item 9 Labs Corp’s EPS estimate?
Item 9 Labs Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Item 9 Labs Corp have?
Item 9 Labs Corp has 701,806,000 shares outstanding.
What happened to Item 9 Labs Corp’s price movement after its last earnings report?
Item 9 Labs Corp reported an EPS of -$0.034 in its last earnings report, beating expectations of -$0.04. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Item 9 Labs Corp?
Currently, no hedge funds are holding shares in INLB
Company Description
Item 9 Labs Corp
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
Windtree Therapeutics
―
Entero Therapeutics
―
ReShape Lifesciences
―
cbdMD
―
Evaxion Biotech
―